Our Latest News

Stay up to date on our latest research and more!

Precision Epigenomics Announces Closing of $1.5M Series A1 Funding

With this funding, Precision Epigenomics has raised more than $3.9M in investments helping move...

Sep 10, 2024

This award will lead to the development of EPISEEK-MPE, a multi-cancer detection test, using...

Aug 27, 2024

Precision Epigenomics Inc. announced today that it was selected by...

Apr 2, 2024

Precision Epigenomics Inc. presents a bioinformatics study...

Feb 14, 2024

Precision Epigenomics Inc. presents a pilot study of the performance of EPISEEK™ for...

Feb 10, 2024

Precision Epigenomics Inc. announced the publication of scientific data demonstrating the diagnostic efficiency of its multi-cancer detection...

Feb 9, 2024

Precision Epigenomics Inc. presents results of the performance of the EPISEEK-MPE™ test at the...

Feb 8, 2024

Precision Epigenomics Announces Patent Granted by USPTO, Strengthening the Company’s...

Jan 24, 2024

Precision Epigenomics Inc. and Arizona State University collaborators are awarded a training...

Jan 20, 2024

Precision Epigenomics Inc. and University of Arizona collaborators awarded a pilot project to...

Aug 14, 2023